Study Details

Back
Study ID 4070-CL-0020
Study Title Phase 2 Dose-finding Study of ASP4070 - A Randomized, Double-blind, Placebo-controlled, Dose-finding Study in Patients With Cedar Pollinosis Using an Environmental Exposure Chamber -
Clinicaltrials.gov Identifier NCT03101267
Compound Name ASP4070
Medical Indication or Disease Pollinosis
Study Sponsor Astellas Pharma Inc
Collaborator Immunomic Therapeutics, Inc.
Study Start Date 13-Apr-2017
Study Completion Date 27-Oct-2018
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS